missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Réactifs biochimiques
  4. Peptides
  5. PEP1214

Invitrogen™ Human OGFOD1 Synthetic Peptide

Numéro de catalogue. PEP1214
Modifier l'affichage
Click to view available options
Quantity:
50 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantity
PEP1214 50 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. PEP1214 Fournisseur Invitrogen™ Code fournisseur PEP1214

Description

Synthetic Peptide

This peptide corresponds to 18 amino acid peptide near the carboxy terminus of human OGFOD1. PEP-1214 can be used as a blocking peptide with polyclonal antibody PA5-21100.

OGFOD1, a member of the 2-OG-Fe(II) dioxygenase family, plays an important role in ischemic survival and stress. It is an oxidoreductase containing a Prolyl 4-hydroxylase alpha subunit. An OGFOD1 iron binding residue is required for ATPAF1 gene expression. As a novel stress granule component, OGFOD1 plays important proapoptotic roles in the regulation of translation and HRI-mediated phosphorylation of eIF2alpha in cells.

Spécifications

Species Human
Purification Method purified
Accession Number Q8N543
Common Name OGFOD1
Concentration 200 μg/mL
Format Liquid
Formulation PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
Gene Alias 2-oxoglutarate and iron dependent oxygenase domain containing 1; 2-oxoglutarate and iron-dependent oxygenase domain containing 1; 2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1; 4930415J21Rik; AA387199; AA939912; AW061076; Kiaa1612; mKIAA1612; OGFOD1; Prolyl 3-hydroxylase OGFOD1; RGD1308848; Termination and polyadenylation 1 homolog; TPA1; TPA1, termination and polyadenylation 1, homolog; uS12 prolyl 3-hydroxylase
Gene Symbol OGFOD1
Lyophilized No
Preservative Sodium azide
Product Type Peptide
Quantity 50 μg
Regulatory Status RUO
Afficher plus de résultats Afficher moins de résultats